Spatiotemporal relations between longitudinal gray matter and white matter lesion changes in multiple sclerosis – A combined parametric and non-parametric voxel-based morphometry study
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
Autorzy:
Uccelli A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research (CEBR), University of Genova, Largo Daneo 3, 16132, Genoa, Italy. .; IRCCS Ospedale Policlinico San Martino, Genoa, Italy. . Laroni A; Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health and Center of Excellence for Biomedical Research (CEBR), University of Genova, Largo Daneo 3, 16132, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Brundin L; Karolinska Institutet, R3:04 Karolinska University Hospital 171 76, Stockholm, Sweden. Clanet M; CHU Toulouse, Université Paul Sabatier, INSERM UMR, 1043, Toulouse, France. Fernandez O; Instituto de Investigación Biomédica de Málaga (IBIMA), Regional University Hospital of Malaga, Malaga, Spain. Nabavi SM; Department of Brain and Cognitive Sciences, Royan Institute for Stem Cell Biology and Technology, Royan, Iran.; ACCR, Iran and Regenerative Biomedicine Center, MS, Neurology Clinic and Research Unit, Tehran, Iran. Muraro PA; Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK. Oliveri RS; Cell Therapy Unit, Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. RadueEW; Medical Image Analysis Centre Basel (MIAC AG), Basel, Switzerland. Sellner J; Department of Neurology, Christian Doppler Medical Center, Paracelsus Medical University, Salzburg, Austria. Soelberg Sorensen P; Danish MS Center Department of Neurology, University of Copenhagen and Rigshospitalet, Copenhagen, Denmark. Sormani MP; Department of Health Sciences, University of Genoa, Genoa, Italy. Wuerfel JT; Medical Image Analysis Centre Basel (MIAC AG), Basel, Switzerland.; Department of Biomedical Engineering, University Basel, Basel, Switzerland. Battaglia MA; Italian Multiple Sclerosis Foundation, Genoa, Italy.; Department of Life Sciences, University of Siena, Siena, Italy. Freedman MS; Department of Medicine (Neurology), University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.
Autorzy:
Nakamura Y; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Gaetano L; Medical Image Analysis Center (MIAC AG), Marktgasse 8, 4051, Basel, Switzerland.; Neurology and Department of Biomedicine, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. Matsushita T; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Anna A; Medical Image Analysis Center (MIAC AG), Marktgasse 8, 4051, Basel, Switzerland.; Department of Biomedical Engineering, University of Basel, Marktgasse 8, 4051, Basel, Switzerland. Sprenger T; DKD Helios Klinik Wiesbaden, Aukammallee 33, 65191, Wiesbaden, Germany. RadueEW; Biomedical Research and Education GmbH, Mittlere Strasse 91, 4031, Basel, Switzerland. Wuerfel J; Medical Image Analysis Center (MIAC AG), Marktgasse 8, 4051, Basel, Switzerland.; Department of Biomedical Engineering, University of Basel, Marktgasse 8, 4051, Basel, Switzerland. Bauer L; Medical Image Analysis Center (MIAC AG), Marktgasse 8, 4051, Basel, Switzerland.; Klinikum rechts der Isar, Department of Neurology, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. Amann M; Medical Image Analysis Center (MIAC AG), Marktgasse 8, 4051, Basel, Switzerland.; Neurology and Department of Biomedicine, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.; Division of Diagnostic and Interventional Neuroradiology, Department of Radiology, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. Shinoda K; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Isobe N; Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Yamasaki R; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. Saida T; Institute of Neurotherapeutics, 16-1 Nishinokyoukasugachou, Nakagyo-ku, Kyoto, 604-8453, Japan.; Department of Neurology, Kyoto Min-Iren-Central Hospital, 16-1 Nishinokyoukasugachou, Nakagyo-ku, Kyoto, 604-8453, Japan. Kappos L; Neurology and Department of Biomedicine, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. Kira JI; Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2018 Sep 05; Vol. 15 (1), pp. 255. Date of Electronic Publication: 2018 Sep 05.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
